CG
VYNT

Cutler Group’s Vyant Bio, Inc. Common Stock VYNT Stock Holding History

Cutler Group’s Portfolio VYNT Stock Details VYNT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-91
Closed -$2K – 6222
2017
Q3 		$2K Buy
+91
New +$47.4K ﹤0.01% 5227
2016
Q2 		– Sell
-3
Closed -$1K – 7484
2016
Q1 		$1K Buy
+3
New +$1.12K ﹤0.01% 6212

Other funds holding VYNT

SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
PCM
Perkins Capital Management Wayzata, Minnesota $133M AUM 127.86% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
FCM
Fairbanks Capital Management Rancho Santa Fe, California $160M AUM 14.36% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
TSS
Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return
DM
Diker Management New York $112M AUM 59.78% 1-Year Est. Return

Cutler Group's VYNT Position: Q3 2017 in Review

Cutler Group sold out of Vyant Bio, Inc. Common Stock (VYNT) in Q3 2017, closing a stake of 3 shares — an estimated $1.56K sold.

Cutler Group first reported a position in VYNT in Q4 2015 and held it in 7 quarters. The position peaked at $4K in Q4 2015. 26 funds tracked by Wall St. Rank hold VYNT as of Q3 2017.

  • Cutler Group reported no remaining Vyant Bio, Inc. Common Stock position as of Q3 2017 after selling out during the quarter.
  • Cutler Group sold 3 Vyant Bio, Inc. Common Stock shares in Q3 2017, an estimated $1.56K.
  • Cutler Group first reported a position in Vyant Bio, Inc. Common Stock in Q4 2015 and held it in 7 quarters.
  • Cutler Group's Vyant Bio, Inc. Common Stock position peaked at $4K in Q4 2015.
  • 26 funds tracked by Wall St. Rank held Vyant Bio, Inc. Common Stock as of Q3 2017.

Based on Cutler Group's 13F filing for Q3 2017, filed 17 Oct 2017.